Test Price
2,800 AEDโ Home Collection Available
KRT17 Gene Steatocystoma Multiplex Genetic Test in UAE โ 2,800 AED โ DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM โ 11 PM, 7 days).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation from a Consultant Medical Geneticist.
- Insurance Support: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The KRT17 gene test detects pathogenic variants in the KRT17 gene linked to steatocystoma multiplex, aiding dermatologists and geneticists in confirming diagnosis, predicting familial risk, and guiding treatment. This test uses Next-Generation Sequencing (NGS) for full gene coverage with high sensitivity for rare variants, including deep intronic and large rearrangements.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Full gene sequencing with high sensitivity for rare variants | Targeted sequencing; may miss deep intronic or large rearrangements |
| Method | Next-Generation Sequencing (NGS) โ clinically validated | Capillary electrophoresis-based Sanger sequencing |
| Speed (TAT) | 3โ4 Weeks | Often 6โ8 Weeks for full gene coverage |
Physician Insight & Safety Protocols
โAs a DHA-licensed Consultant Medical Geneticist, I emphasize that this test must be interpreted alongside your dermatologistโs clinical evaluation and a complete family pedigree. The results provide powerful molecular confirmation, but never replace clinical judgement. If you observe sudden changes in skin cysts, including rapid growth or pain, please consult your specialist immediately.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
โ ๏ธ Advisory: Medication Continuation
Do not discontinue any prescribed medication without consulting your treating physician. This genetic test is for diagnostic confirmation and does not alter your current dermatological treatment plan.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active systemic infection that may compromise sample quality; unregulated minors without parental consent as per UAE Federal Law No. 2 of 2019 and Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: Rapidly enlarging skin cyst with fever, severe pain, or signs of systemic infection โ seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What is the KRT17 gene test and why is it recommended?
Quick Answer: The KRT17 gene test identifies pathogenic DNA variants in the KRT17 gene causing steatocystoma multiplex. This advanced NGS panel helps your dermatologist or geneticist confirm the diagnosis when multiple sebaceous cysts appear, and it is essential for accurate familial risk assessment and genetic counseling. Early molecular confirmation can prevent unnecessary surgical interventions and guide targeted skin management.
2. How is the sample collected and what should I prepare?
Quick Answer: Our VIP mobile phlebotomy team collects a small blood sample or buccal swab using DNA FTA cards. You can choose blood (one venipuncture), extracted DNA, or a single drop of blood on an FTA cardโideal for pediatric or difficult venous access cases. Before collection, a genetic counseling session (virtual or in-person) is mandatory to draw a full pedigree chart and document clinical history. Avoid anticoagulants or heavy meals right before blood draw, but do not alter prescribed medication without physician approval.
3. How reliable are the results and what if I have a variant of uncertain significance?
Quick Answer: Our ISO 9001:2015 certified NGS workflow delivers >99.9% analytical sensitivity and specificity for KRT17 gene variants. Every report is interpreted by a board-certified molecular pathologist using current clinical guidelines. In rare cases, a variant of uncertain significance (VUS) may be detected โ this is not a diagnosis. We provide a dedicated telephonic consultation to explain its meaning, and recommend periodic follow-up as classification may evolve. All data handling complies with UAE PDPL; genetic information is never shared without explicit consent.
UAE Regulatory & Data Privacy Adherence
- Licensed by Dubai Health Authority (DHA Facility License: 1143).
- Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the use of Information and Communication Technology in Health Fields.
- All clinical testing and patient consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | KRT17 Gene Steatocystoma Multiplex Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Buccal Swab โ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | L72.2 (Steatocystoma multiplex) |
| LOINC Code | 21644-0 (Sequence analysis of specified gene in blood) |
| DHA Facility License & Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians